Miller, Duane D.,Mohler, Michael L.,WU, Zhongzhi,Dalton, James T.,Hong, Seoung-Soo,Srivastava, Devesh
申请号：
AU2013219238
公开号：
AU2013219238C1
申请日:
2013.08.23
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
#$%^&*AU2013219238C120161201.pdf#####ABSTRACT The present invention relates to a novel class of nuclear receptor binding agents (NRBAs). The NRBAs are applicable for use in the prevention and/or treatment of a variety of diseases and 5 conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, inflammatory diseases, oxidative stress related disorders such as Parkinson's and stroke, neurological disorders, ophthalmic disorders, cardiovascular disease, and obesity. 10
